Market Research Logo

Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review

Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has presence in cardiology, pain management, dermatology and ophthalmology. It provides generics in developed markets of USA and branded generics in emerging countries across India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti malarial products to Africa and Global Fund. The company operates seven manufacturing facilities and one research center. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Ajanta Pharma Ltd Key Recent Developments

Apr 10,2017: Ajanta Pharma Provides Update On US FDA Inspection At Dahej Formulation Facility
Feb 09,2017: Ajanta Pharma Provides Update On US FDA Inspection
Jan 24,2017: Ajanta Pharma Announces No import alert on us by US FDA
Jan 24,2017: Ajanta Pharma: PAT up 25%, Income from Operations up 12% in Q3 FY 2017
Oct 26,2016: Ajanta Pharma Reports Revenue Of INR5.16 Billion In Q2 Fiscal 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Ajanta Pharma Ltd - Key Facts 5
Ajanta Pharma Ltd - Key Employees 6
Ajanta Pharma Ltd - Key Employee Biographies 7
Ajanta Pharma Ltd - Major Products and Services 8
Ajanta Pharma Ltd - History 9
Ajanta Pharma Ltd - Company Statement 11
Ajanta Pharma Ltd - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Ajanta Pharma Ltd - Business Description 13
Ajanta Pharma Ltd - Corporate Strategy 14
Ajanta Pharma Ltd - SWOT Analysis 15
SWOT Analysis - Overview 15
Ajanta Pharma Ltd - Strengths 15
Ajanta Pharma Ltd - Weaknesses 16
Ajanta Pharma Ltd - Opportunities 17
Ajanta Pharma Ltd - Threats 18
Ajanta Pharma Ltd - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Ajanta Pharma Ltd, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Apr 10, 2017: Ajanta Pharma Provides Update On US FDA Inspection At Dahej Formulation Facility 30
Feb 09, 2017: Ajanta Pharma Provides Update On US FDA Inspection 31
Jan 24, 2017: Ajanta Pharma Announces No import alert on us by US FDA 32
Jan 24, 2017: Ajanta Pharma: PAT up 25%, Income from Operations up 12% in Q3 FY 2017 33
Oct 26, 2016: Ajanta Pharma Reports Revenue Of INR5.16 Billion In Q2 Fiscal 2017 35
Jul 26, 2016: Ajanta Pharma: PAT up 39%, Operating Revenue up 20% 36
Apr 29, 2016: Ajanta Pharma : Q4 FY 2016 PAT up 43%, Operating Revenue up 14% 37
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Ajanta Pharma Ltd, Key Facts 5
Ajanta Pharma Ltd, Key Employees 6
Ajanta Pharma Ltd, Key Employee Biographies 7
Ajanta Pharma Ltd, Major Products and Services 8
Ajanta Pharma Ltd, History 9
Ajanta Pharma Ltd, Subsidiaries 12
Ajanta Pharma Ltd, Key Competitors 19
Ajanta Pharma Ltd, Ratios based on current share price 20
Ajanta Pharma Ltd, Annual Ratios 21
Ajanta Pharma Ltd, Annual Ratios (Cont...1) 22
Ajanta Pharma Ltd, Annual Ratios (Cont...2) 23
Ajanta Pharma Ltd, Interim Ratios 25
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Ajanta Pharma Ltd, Recent Deals Summary 29
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42
List of Figuress
Ajanta Pharma Ltd, Performance Chart (2013 - 2017)
Ajanta Pharma Ltd, Ratio Charts
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report